Beryl Drugs Revenue

Beryl Drugs had revenue of 53.09M INR in the quarter ending December 31, 2024, a decrease of -30.35%. This brings the company's revenue in the last twelve months to 201.48M, down -32.53% year-over-year. In the fiscal year ending March 31, 2024, Beryl Drugs had annual revenue of 267.30M, down -0.53%.

Revenue (ttm)

201.48M

Revenue Growth

-32.53%

P/S Ratio

0.44

Revenue / Employee

n/a

Employees

n/a

Market Cap

88.65M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	267.30M	-1.41M	-0.53%
Mar 31, 2023	268.71M	122.67M	84.00%
Mar 31, 2022	146.04M	5.11M	3.62%
Mar 31, 2021	140.93M	12.78M	9.97%
Mar 31, 2020	128.15M	-1.45M	-1.12%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Reliance Industries	9,646.93B
HDFC Bank	2,728.47B
Tata Consultancy Services	2,553.24B
Bharti Airtel	1,627.08B
ICICI Bank	2,006.54B
State Bank of India	3,429.39B
Infosys	1,647.16B
Hindustan Unilever	631.21B

Revenue Rankings